Edition:
United Kingdom

Essex Bio-Technology Ltd (1061.HK)

1061.HK on Hong Kong Stock

5.10HKD
8:59am BST
Change (% chg)

HK$-0.05 (-0.97%)
Prev Close
HK$5.15
Open
HK$5.15
Day's High
HK$5.25
Day's Low
HK$5.05
Volume
501,134
Avg. Vol
504,987
52-wk High
HK$9.60
52-wk Low
HK$4.58

Latest Key Developments (Source: Significant Developments)

Essex Bio-Technology Says Unit Obtained Approval From State Drug Administration For A Product
Wednesday, 22 Aug 2018 

Aug 22 (Reuters) - Essex Bio-Technology Ltd <1061.HK>::GETS APPROVAL TO COMMERCIALISE PRESERVATIVE-FREE SINGLE-DOSE SODIUM HYALURONATE EYE DROPS IN CHINA.SAYS UNIT OBTAINED APPROVAL FROM STATE DRUG ADMINISTRATION FOR PRODUCT.  Full Article

Essex Bio-Technology Says Unit to Make Investment In Chengdu Shanggong
Wednesday, 18 Jul 2018 

July 18 (Reuters) - Essex Bio-Technology Ltd <1061.HK>::ZHUHAI ESSEX SHALL MAKE AN INVESTMENT OF RMB20 MILLION AS CAPITAL CONTRIBUTION IN CHENGDU SHANGGONG.  Full Article

Essex Bio-Technology's Unit Gets Approval For Commercialisation Of Eye Drops In China
Tuesday, 17 Jul 2018 

July 17 (Reuters) - Essex Bio-Technology Ltd <1061.HK>::UNIT GETS APPROVAL FROM STATE DRUG ADMINISTRATION FOR COMMERCIALISATION OF SINGLE-DOSE LEVOFLOXACIN EYE DROPS IN CHINA.  Full Article

Essex bio-technology terminates proposed KDR programme​
Monday, 16 Oct 2017 

Oct 16 (Reuters) - Essex Bio-technology Ltd <1061.HK>::Terminated proposed KDR programme​.‍KDR programme termination to not have adverse effect on co's financial position​.  Full Article

Essex Bio-Technology enters research project deal with AC Immune
Monday, 22 May 2017 

May 22 (Reuters) - Essex Bio-technology Ltd <1061.HK>:Company entered into research project agreement with ACI.Deal to collaborate in pre-clinical and clinical co-development of novel biological therapeutic to treat neurodegenerative diseases.  Full Article